Although not easily scalable, this treatment is still a relevant strategy to potentially help mass remission. With three patients now cured, in the long fight against HIV, AIDS, and cancer, another case of viral remission provides reason for hope for the future.
Due to the specific nature of the treatment and its high risk, it's unlikely that bone-marrow replacement will be rolled out on a larger scale to those who do not have leukemia. While the news is regardless positive, the road to fully curing HIV still promises to be long and difficult — if not impossible.
There is a 40% chance that before 2032 a vaccine against HIV-1 will be approved by the USA, UK, EU, or Canada, according to the Metaculus prediction community.